secwatch.observer — SEC 8-K summary
======================================

Issuer:     GERON CORP (GERN)
CIK:        0000886744
Form:       8-K
Filed at:   2023-09-29T23:59:59+00:00
Accession:  0000950170-23-050580
Event type: regulatory
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Geron's imetelstat MAA for lower-risk MDS validated by EMA for review
---------------------------------------------------------------------

- MAA for imetelstat in transfusion-dependent anemia with lower-risk MDS validated by EMA.
- Review by CHMP under centralized procedure covering all 27 EU states plus Iceland, Norway, Liechtenstein.
- Expected review period of approximately 14 months.
- Submission made in September 2023; now under regulatory review.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/886744/000095017023050580/0000950170-23-050580-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/886744/000095017023050580/gern-20230928.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-050580

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer